Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Therapeutic Solutions International Inc TSOI

Therapeutic Solutions International, Inc. is focused on immune modulation for the treatment of several specific diseases. The Company is developing a range of immune-modulatory agents to target certain cancers, schizophrenia, suicidal ideation, and traumatic brain injury (TBI), and for daily health. Its flagship product, QuadraMune, is a multi-patented synergistic blend of pterostilbene... see more

Recent & Breaking News (OTCPK:TSOI)

Therapeutic Solutions International Develops Cytokine Based Diagnostic Test for Preterm Labor and Complications of Pregnancy

Marketwired September 21, 2015

Therapeutic Solutions International Announces Engagement With PLS CPA's

Marketwired September 15, 2015

Therapeutic Solutions International Files Patient on Cytokine Modulation to Prevent Pregnancy Loss and Pre-Term Labor

Marketwired September 8, 2015

Therapeutic Solutions International Acquires Preterm Labor and Miscarriage Intellectual Property From OmniBiome Therapeutics Inc.

Marketwired August 31, 2015

Company Expands Immunotherapy Based Product Pipeline by Filing New Patent Application

Marketwired July 22, 2015

Company Expands Immunotherapy Based Product Pipeline by Filing New Patent Application

Marketwired July 22, 2015

Therapeutic Solutions International Files Patent on Cancer Immune Modulation Using Its ProJuvenol(TM) Product

Marketwired July 9, 2015

Therapeutic Solutions Announces Shipping of ProJuvenol(TM) and T-Rx(TM)

Marketwired May 18, 2015

Therapeutic Solutions Announces New Product Line and Launch of E-Commerce Platform

Marketwired May 4, 2015

Therapeutic Solutions International Updates Shareholders

Marketwired February 3, 2015

Therapeutic Solutions International, Inc. Announces New Division

Marketwired March 26, 2014

Therapeutic Solutions International, Inc. Announces New Division

Marketwired March 26, 2014

Quture (QUTR) Announces Agreement With Therapeutic Solutions International, Inc. (TSOI) for QualVal Services Implementing QualOptima Analytics

Marketwired October 3, 2013

Therapeutic Solutions International, Inc. (TSOI) Announces Agreement With Quture International, Inc. (QUTR) for QualVal Services Implementing QualOptima Analytics

Marketwired October 3, 2013

Therapeutic Solutions International, Inc. Announces Memorandum of Understanding With ZYPPAH, Inc.

Marketwired August 6, 2013

Therapeutic Solutions International, Inc. Announces Definitive Agreement With S4S (UK) Limited

Marketwired June 18, 2013

Therapeutic Solutions International, Inc. Announces Formation of Scientific Advisory Board

Marketwired June 11, 2013